Here are five facts:
1. Royal Bank of Canada has an “outperform” rating on AmSurg shares.
2. The firm’s price objective indicates a 32.58 percent potential upside compared to AmSurg’s previous close.
3. On Jan. 5, AmSurg opened the day trading at $65.62.
4. The company’s 50-day moving average is $54.74 and a 200-day moving average is $30.30.
5. AmSurg’s market cap totals $3.53 billion.
More articles on surgery centers:
From total knees to hip arthoplasties: How Premier Orthopedic Surgery Center is tackling the evolving outpatient landscape
4 recent ASC acquisitions — Jan. 5, 2016
Envision Healthcare Corp. acquires Sunshine Radiology — 4 notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.